Compare SNY & BLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNY | BLK |
|---|---|---|
| Founded | 1994 | 1988 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4B | 180.1B |
| IPO Year | N/A | 1999 |
| Metric | SNY | BLK |
|---|---|---|
| Price | $48.69 | $1,089.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 16 |
| Target Price | $61.50 | ★ $1,253.69 |
| AVG Volume (30 Days) | ★ 2.6M | 673.7K |
| Earning Date | 01-29-2026 | 01-14-2026 |
| Dividend Yield | ★ 3.28% | 1.91% |
| EPS Growth | ★ 105.93 | N/A |
| EPS | 8.67 | ★ 38.83 |
| Revenue | ★ $53,890,648,839.00 | $22,885,000,000.00 |
| Revenue This Year | $2.48 | $18.68 |
| Revenue Next Year | $6.47 | $16.56 |
| P/E Ratio | ★ $5.61 | $28.04 |
| Revenue Growth | N/A | ★ 18.20 |
| 52 Week Low | $44.62 | $773.74 |
| 52 Week High | $60.12 | $1,219.94 |
| Indicator | SNY | BLK |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | 56.62 |
| Support Level | $47.80 | $1,057.15 |
| Resistance Level | $49.24 | $1,078.86 |
| Average True Range (ATR) | 0.64 | 19.39 |
| MACD | -0.16 | 9.22 |
| Stochastic Oscillator | 29.77 | 83.39 |
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
BlackRock is the largest asset manager in the world, with $13.464 trillion in assets under management at the end of September 2025. Its product mix is diverse, with 55% of managed assets in equity strategies, 24% in fixed income, 9% in multi-asset classes, 7% in money market funds, and 5% in alternatives. Passive strategies account for more than two-thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which, by our calculations, account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one-third of managed assets coming from investors domiciled outside the US and Canada.